Its overexpression in advanced thymic carcinoma patients indicates its potential role in the pathogenesis of this malignancy, exerting negative modulation on cytotoxic CD8+ cells and promoting the activation of CD4+ regulatory T cells, thereby fostering self-tolerance and facilitating tumorigenesis (101). Here, CD8A is linked to thymic carcinoma.